SNDX
Syndax Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +8.3% ·
Aktienfluss -10.7% ·
neue Nettopositionen +7.7%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 93 | -1 | 57.50M | $1.26B | +8 | −9 |
| Q1 2026 | 97 | +6 | 52.14M | $1.22B | +10 | −4 |
| Q4 2025 | 91 | -3 | 57.71M | $1.21B | — | −3 |
| Q3 2025 | 20 | +1 | 39.69M | $610.59M | +1 | — |
| Q2 2025 | 16 | +1 | 29.55M | $276.77M | +1 | — |
| Q1 2025 | 12 | -1 | 16.71M | $205.25M | — | −1 |
| Q4 2024 | 13 | +1 | 16.01M | $211.65M | +1 | — |
| Q3 2024 | 11 | -1 | 14.02M | $269.82M | — | −1 |
| Q2 2024 | 12 | — | 17.35M | $356.12M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passiv) | 3.92M | — | $51.79M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 1.97M | -0.2% | $26.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 1.97M | -0.2% | $26.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.92M | -31.1% | $25.33M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.09M | +3103.4% | $14.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.09M | +3103.4% | $14.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 680.97K | Neu | $9.00M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 669.82K | -24.4% | $8.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 621.84K | -23.9% | $8.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 586.81K | -47.6% | $7.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 184.12K | -47.8% | $2.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 184.12K | -47.8% | $2.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 65.21K | +156.6% | $862,116 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 65.21K | +156.6% | $862,116 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 65.21K | +156.6% | $862,116 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 57.02K | +16.5% | $754,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Marshall Wace ✦ | 12.62K | -98.7% | $166,891 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Marshall Wace ✦ | 12.62K | -98.7% | $166,891 | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Renaissance Technologies | $9.00M | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 244 Inhaber, 99.11M Anteile, $2.29B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.